OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Placebo-Controlled Clinical Trial of IncobotulinumtoxinA for Sialorrhea in Children
Steffen Berweck, Marcin Bonikowski, Heakyung Kim, et al.
Neurology (2021) Vol. 97, Iss. 14
Open Access | Times Cited: 23

Showing 23 citing articles:

Using Neuromodulators for Salivary, Eccrine, and Apocrine Gland Disorders
Susruthi Rajanala, Nicole Salame, Jeffrey S. Dover
Dermatologic Surgery (2024) Vol. 50, Iss. 9S, pp. S103-S111
Closed Access | Times Cited: 5

Abobotulinumtoxin A injections for the chronic sialorrhea correction in children: Russian retrospective multicenter study
O. A. Klochkova, А. Л. Куренков, G.V. Argunova, et al.
S S Korsakov Journal of Neurology and Psychiatry (2025) Vol. 125, Iss. 1, pp. 53-53
Closed Access

Efficacy and safety of botulinum toxin for treating sialorrhea: A systematic review and meta‐analysis
Ya‐Chien Yu, Chen‐Chih Chung, Yu‐Kang Tu, et al.
European Journal of Neurology (2021) Vol. 29, Iss. 1, pp. 69-80
Closed Access | Times Cited: 19

Sialorrhea in children with mucopolysaccharidosis type II (a review of several clinical cases)
А. Л. Куренков, Tatyana V. Podkletnova, Б. И. Бурсагова
L O Badalyan Neurological Journal (2024) Vol. 5, Iss. 2, pp. 108-115
Closed Access | Times Cited: 1

Real-World Observational Analysis of Clinical Characteristics and Treatment Patterns of Patients with Chronic Sialorrhea
Michael A. Hast, Amanda M. Kong, Jenna Abdelhadi, et al.
Toxins (2024) Vol. 16, Iss. 8, pp. 366-366
Open Access | Times Cited: 1

BoNT clinical trial update: Sialorrhea
Emily T. Tamadonfar, Mark Lew
Toxicon (2023) Vol. 226, pp. 107087-107087
Closed Access | Times Cited: 3

Comparative Efficacy and Side Effect Profiles of Interventions for Pediatric Saliva Control: A Cohort Study
Apostolos Papandreou, Aoife Mahony, Anne Breaks, et al.
The Journal of Pediatrics (2023) Vol. 265, pp. 113803-113803
Closed Access | Times Cited: 3

Comparing the evidence for botulinum neurotoxin injections in paediatric anterior drooling: a scoping review
Lynn B. Orriëns, Karen van Hulst, J.J.W. van der Burg, et al.
European Journal of Pediatrics (2023) Vol. 183, Iss. 1, pp. 83-93
Open Access | Times Cited: 3

Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations
Wolfgang H. Jost, Tobias Bäumer, Andrea Bevot, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 3

Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis
Steffen Berweck, Marta Banach, Deborah Gaebler‐Spira, et al.
Toxins (2022) Vol. 14, Iss. 9, pp. 585-585
Open Access | Times Cited: 5

Crocodile tear syndrome treated with lacrimal gland incobotulinum toxin A injection: a case series
Kathleen Krivda, Carson Clabeaux, Vladimir S. Yakopson
Digital Journal of Ophthalmology (2023) Vol. 29, Iss. 4
Open Access | Times Cited: 2

Behandlung der Sialorrhoe mit Botulinum Neurotoxin Typ A – Konsentierte Praxisempfehlungen für Kinder und Erwachsene
Wolfgang H. Jost, Tobias Bäumer, Andrea Bevot, et al.
Fortschritte der Neurologie · Psychiatrie (2022) Vol. 90, Iss. 05, pp. 212-221
Open Access | Times Cited: 4

Therapie der Sialorrhoe mit Botulinumtoxin – ein Update
Wolfgang H. Jost, Tobias Bäumer, Steffen Berweck, et al.
Fortschritte der Neurologie · Psychiatrie (2022) Vol. 90, Iss. 05, pp. 222-232
Closed Access | Times Cited: 3

Dysphagia in Parkinson's disease: A bibliometric and visualization analysis from 2002 to 2022
Weiming Sun, Keqi Wan, Shilin Li, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30191-e30191
Open Access

The When, Why, and How of Using Glycopyrronium to Diminish Drooling in Children with Neurodevelopmental Disabilities: Implications for Clinical Practice
Lynn B. Orriëns, J.J.W. van der Burg, Frank J. A. van den Hoogen, et al.
European Journal of Paediatric Neurology (2024) Vol. 51, pp. 24-31
Open Access

Russian consensus on the use of incobotulinumtoxinA in children with cerebral palsy for the treatment of spasticity and sialorrhea
А. Л. Куренков, Л. М. Кузенкова, Б. И. Бурсагова, et al.
Neurology neuropsychiatry Psychosomatics (2022) Vol. 14, Iss. 2, pp. 117-125
Open Access | Times Cited: 1

Dose selection of Incobotulinumtoxin A for the treatment of spasticity and sialorrhea in cerebral palsy: results of a retrospective multicenter study
А. Л. Куренков, Oleg Agranovich, Л. М. Кузенкова, et al.
L O Badalyan Neurological Journal (2021) Vol. 2, Iss. 4, pp. 189-202
Closed Access | Times Cited: 1

Response to Letter to Editor: Botulinum Toxin A in the Management of Pediatric Sialorrhea: A Systematic Review
Tiffany Heikel, Jessyka G. Lighthall
Annals of Otology Rhinology & Laryngology (2023) Vol. 132, Iss. 12, pp. 1698-1699
Closed Access

The use of IncobotulinumtoxinA in spastic forms of cerebral palsy: a review of randomized clinical trials
А. Л. Куренков, Б. И. Бурсагова, А. Р. Артеменко
L O Badalyan Neurological Journal (2023) Vol. 3, Iss. 4, pp. 158-171
Open Access

Treatment of sialorrhea in adults and children using botulinum toxin type A
A. F. Ivolgin, Tatyana Y. Avseitseva, А. Л. Куренков, et al.
L O Badalyan Neurological Journal (2023) Vol. 4, Iss. 4, pp. 200-207
Open Access

Page 1

Scroll to top